Better healthcare needs the right people and appropriate implementation
This article was originally published in Scrip
The US health insurance expansion legislation signed into law on 23 March 2010 extends coverage to more Americans and follows the legislation expanding drug coverage for seniors in December 2003 (Medicare Part D). Controversy surrounds the subject of who benefits, who pays, how healthcare is delivered and what proportion of the healthcare dollar is controlled by the government, employers and individuals. The US pharmaceutical industry has supported both the 2003 and 2010 legislations. The industry, in principle, has supported expanded coverage for several years.
You may also be interested in...
I have returned from the PhRMA Annual Meeting in San Diego. My recent book was handed out to all registrants of the meeting and I got to hear from many of them. I appreciate feedback. And the takeaways from my book are the same as my own personal playbook.
Successors, flankers and toppers are product lifecycle management (LCM) categories used by pharma executives, although they may be referred to differently by other companies.
Early in my career, I learned the essential principle of product lifecycle management (LCM): "Do LCM because you create value for the patient or the customer – not just because you want to get more profit out of each molecule."